Matthew Hamilton Rosenberg’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,102
Closed -$25.6K 828
2024
Q4
$25.6K Hold
3,102
0.01% 510
2024
Q3
$23.7K Buy
+3,102
New +$28.6K 0.01% 529
2024
Q2
Sell
-3,102
Closed -$36.4K 861
2024
Q1
$36.4K Hold
3,102
0.01% 466
2023
Q4
$33.5K Hold
3,102
0.01% 478
2023
Q3
$42.9K Hold
3,102
0.01% 442
2023
Q2
$37.1K Hold
3,102
0.01% 475
2023
Q1
$36.3K Hold
3,102
0.01% 521
2022
Q4
$52.2K Hold
3,102
0.02% 450
2022
Q3
$36K Hold
3,102
0.01% 515
2022
Q2
$47K Hold
3,102
0.02% 475
2022
Q1
$48K Hold
3,102
0.02% 466
2021
Q4
$26K Buy
+3,102
New +$26.7K 0.01% 499

Other funds holding PTEN

Matthew Hamilton Rosenberg's PTEN Position: Q1 2025 in Review

Matthew Hamilton Rosenberg sold out of Patterson-UTI (PTEN) in Q1 2025, closing a stake of 3,102 shares — an estimated $25.6K sold.

Matthew Hamilton Rosenberg first reported a position in PTEN in Q4 2021 and held it in 12 quarters. The position peaked at $52.2K in Q4 2022. 381 funds tracked by Wall St. Rank hold PTEN as of Q1 2025.

  • Matthew Hamilton Rosenberg reported no remaining Patterson-UTI position as of Q1 2025 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 3,102 Patterson-UTI shares in Q1 2025, an estimated $25.6K.
  • Matthew Hamilton Rosenberg first reported a position in Patterson-UTI in Q4 2021 and held it in 12 quarters.
  • Matthew Hamilton Rosenberg's Patterson-UTI position peaked at $52.2K in Q4 2022.
  • 381 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2025.

Based on Matthew Hamilton Rosenberg's 13F filing for Q1 2025, filed 28 Apr 2025.